Geoffrey Parker

Geoffrey M.
Parker is currently an Independent Director at Perrigo Co. Plc since 2016, a Director at Better Therapeutics LLC since 2021, and Chief Financial Officer & Executive Vice President at Allogene Therapeutics, Inc. starting in 2024.
Formerly, Mr. Parker was an Independent Director at ChemoCentryx, Inc. from 2009 to 2022, Independent Director at Sunesis Pharmaceuticals, Inc. from 2016 to 2017, Director at Genoptix, Inc., Independent Director at Genomic Health, Inc. from 2016 to 2019, Independent Director at Better Therapeutics, Inc. from 2021 to 2024, MD & Partner-Investment Banking Division at The Goldman Sachs Group, Inc. from 1997 to 2009, Chief Business Officer at InteKrin Therapeutics, Inc. from 2009 to 2010, Chief Financial Officer & Executive Vice President at Tricida, Inc. from 2020 to 2021, Vice President at Feibusch & Co., Inc. from 1995 to 1997, Chief Financial Officer & Executive Vice President at Anacor Pharmaceuticals LLC in 2015, and Chief Financial Officer & Senior Vice President at Anacor, Inc. from 2012 to 2015.
Education includes undergraduate studies at Dartmouth College and an MBA from Stanford Graduate School of Business.